Medifast
MED
#9560
Rank
A$0.18 B
Marketcap
A$16.48
Share price
-1.37%
Change (1 day)
-22.25%
Change (1 year)

Earnings for Medifast (MED)

Earnings in 2026 (TTM): -A$28.85 Million

According to Medifast's latest financial reports the company's current earnings are A$0.31 Billion. In 2025 the company made an earning of -A$20.36 Million a decrease over its 2024 earnings that were of A$4.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Medifast from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$28.85 Million41.74%
2025 -A$20.36 Million-593.64%
2024 A$4.12 M-97.72%
2023 A$0.18 B-31.61%
2022 A$0.26 B-14.56%
2021 A$0.30 B61.25%
2020 A$0.19 B47.36%
2019 A$0.13 B31.82%
2018 A$98.89 M74.26%
2017 A$56.74 M47.56%
2016 A$38.45 M-6.36%
2015 A$41.07 M-16.28%
2014 A$49.05 M2%
2013 A$48.09 M44.4%
2012 A$33.3 M-16.75%
2011 A$40.01 M-12.14%
2010 A$45.53 M63.85%
2009 A$27.79 M136.71%
2008 A$11.74 M35.74%
2007 A$8.65 M-142.56%
2006 -A$20.33 Million-448.43%
2005 A$5.83 M35.62%
2004 A$4.3 M-16.51%
2003 A$5.15 M
2000 A$0.69 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.12 Billion 309.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
-A$0.12 Billion 301.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
-A$15.81 Million-43.43%๐Ÿ‡บ๐Ÿ‡ธ USA